A Giustina

Summary

Affiliation: University of Brescia
Country: Italy

Publications

  1. ncbi request reprint Diagnosis and treatment of acromegaly and its complications: consensus guidelines
    S Bonadonna
    Department of Internal Medicine, Endocrine Section, University of Brescia, Italy
    J Endocrinol Invest 28:43-7. 2005
  2. ncbi request reprint Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone
    A Giustina
    Department of Internal Medicine, University of Brescia, Italy
    J Clin Endocrinol Metab 82:1210-9. 1997
  3. ncbi request reprint Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients
    A Giustina
    Department of Internal Medicine, University of Brescia, Italy
    Diabetes 47:423-30. 1998
  4. ncbi request reprint Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone
    A Giustina
    Department of Internal Medicine, Brescia, Italy
    Regul Pept 70:49-54. 1997
  5. ncbi request reprint [Growth hormone secretion in heart failure]
    A Giustina
    Dipartimento di Scienze Mediche e Chirurgiche, Universita degli Studi di Brescia, Brescia, Italy
    Minerva Endocrinol 28:1-11. 2003
  6. doi request reprint Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency
    G Mazziotti
    Department of Medical and Surgical Sciences, Montichiari Hospital, University of Brescia, Via Ciotti 154, 25018 Montichiari, Italy
    Eur J Endocrinol 163:15-20. 2010
  7. doi request reprint Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test
    G Mazziotti
    Department of Medical and Surgical Sciences, University of Brescia, Brescia, Italy
    Neuroendocrinology 88:299-304. 2008
  8. ncbi request reprint Resistance to somatostatin analogs in acromegaly: an evolving concept?
    M Gola
    Department of Internal Medicine, University of Brescia, Brescia, Italy
    J Endocrinol Invest 29:86-93. 2006
  9. ncbi request reprint Incidence of subclinical hypothyroidism and its influence on cognitive performance and on metabolic aspects in an hospitalized geriatric population
    S Bossoni
    University of Brescia, Brescia, Italy
    J Endocrinol Invest 25:75-6. 2002
  10. ncbi request reprint Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro
    G Tulipano
    Endocrine Section, Department of Internal Medicine, University of Brescia, Italy
    Neuroendocrinology 73:344-51. 2001

Detail Information

Publications58

  1. ncbi request reprint Diagnosis and treatment of acromegaly and its complications: consensus guidelines
    S Bonadonna
    Department of Internal Medicine, Endocrine Section, University of Brescia, Italy
    J Endocrinol Invest 28:43-7. 2005
    ..This review paper summarizes the main points of the three consensus statements published following these three workshops...
  2. ncbi request reprint Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone
    A Giustina
    Department of Internal Medicine, University of Brescia, Italy
    J Clin Endocrinol Metab 82:1210-9. 1997
    ..e. directly at the pituitary level, and also at hypothalamic loci, possibly increasing both GHRH and somatostatin release...
  3. ncbi request reprint Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients
    A Giustina
    Department of Internal Medicine, University of Brescia, Italy
    Diabetes 47:423-30. 1998
    ....
  4. ncbi request reprint Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone
    A Giustina
    Department of Internal Medicine, Brescia, Italy
    Regul Pept 70:49-54. 1997
    ..Moreover, the observation that cells not sensitive to GHRH can be significantly stimulated by hexarelin strongly suggests that GHRPs and GHRH have two distinct sites and modes of action at the pituitary level...
  5. ncbi request reprint [Growth hormone secretion in heart failure]
    A Giustina
    Dipartimento di Scienze Mediche e Chirurgiche, Universita degli Studi di Brescia, Brescia, Italy
    Minerva Endocrinol 28:1-11. 2003
    ..Particularly attention should be given to those patients that present a peripheric GH resistance. On the other hand, those patients with a reduced pituitary GH reserve are supposed to have very beneficial effects from GH treatment...
  6. doi request reprint Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency
    G Mazziotti
    Department of Medical and Surgical Sciences, Montichiari Hospital, University of Brescia, Via Ciotti 154, 25018 Montichiari, Italy
    Eur J Endocrinol 163:15-20. 2010
    ..We aimed to evaluate whether the prevalence of vertebral fractures may be influenced by glucocorticoid over-replacement in hypopituitary males with GHD...
  7. doi request reprint Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test
    G Mazziotti
    Department of Medical and Surgical Sciences, University of Brescia, Brescia, Italy
    Neuroendocrinology 88:299-304. 2008
    ..The results of our study provide evidence that the galanin test may be of value for the diagnosis of acromegaly in patients with type 2 diabetes mellitus...
  8. ncbi request reprint Resistance to somatostatin analogs in acromegaly: an evolving concept?
    M Gola
    Department of Internal Medicine, University of Brescia, Brescia, Italy
    J Endocrinol Invest 29:86-93. 2006
    ....
  9. ncbi request reprint Incidence of subclinical hypothyroidism and its influence on cognitive performance and on metabolic aspects in an hospitalized geriatric population
    S Bossoni
    University of Brescia, Brescia, Italy
    J Endocrinol Invest 25:75-6. 2002
  10. ncbi request reprint Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro
    G Tulipano
    Endocrine Section, Department of Internal Medicine, University of Brescia, Italy
    Neuroendocrinology 73:344-51. 2001
    ..We conclude that the availability of somatostatin analogs selective for SSTR5 will enhance the treatment potency and spectrum in acromegaly...
  11. ncbi request reprint Low T3 syndrome and outcome in elderly hospitalized geriatric patients
    S Bossoni
    University of Brescia, Brescia, Italy
    J Endocrinol Invest 25:73-4. 2002
  12. ncbi request reprint Effects of calcitonin on GH response to pyridostigmine in combination with hGHRH (1-29) NH2 in normal adult subjects
    A Giustina
    Cattedra di Clinica Medica, University of Brescia, Italy
    Clin Endocrinol (Oxf) 33:375-80. 1990
    ..We conclude that sCT is able to inhibit GHRH-stimulated GH secretion in man without influencing the hypothalamic somatostatinergic tone...
  13. doi request reprint Current management practices for acromegaly: an international survey
    A Giustina
    Department of Medical and Surgical Sciences, University of Brescia, Endocrine Service, Montichiari Hospital, Via Ciotti 154, 25018 Montichiari, Italy
    Pituitary 14:125-33. 2011
    ..The observation that most centers followed consensus statement recommendations encourages the future utility of these workshops aimed to create uniform management standards for acromegaly...
  14. ncbi request reprint Effects of the selective estrogen receptor modulator LY117018 on growth hormone secretion: In vitro studies
    G Tulipano
    Endocrine Section, Department of Intternal Medicine, University of Brescia, Brescia, Italy
    Metabolism 53:563-70. 2004
    ..LY117018 also showed an estrogen-like activity, inducing the proliferation of rat pituitary GH-secreting adenomatous cells (GH1)...
  15. ncbi request reprint Glucocorticoid-induced osteoporosis and parathyroid hormone
    R Carpinteri
    Department of Medical and Surgical Sciences, University of Brescia, Brescia, Italy
    J Endocrinol Invest 33:16-21. 2010
    ..Teriparatide (1-34PTH) has been studied in patients with GIO with effects on bone mineral density and on fracture risk which were shown to be superior to those obtained with alendronate...
  16. ncbi request reprint Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group
    E De Menis
    Department of Internal Medicine, General Hospital, v Monte Grappa 30, 31044 Montebelluna, Italy
    J Endocrinol Invest 34:60-4. 2011
    ..Continuous positive airway pressure is the cornerstone of therapy, but patients' acceptance may be critical. Control of GH/IGF-I secretion is important to improve SAS. Management of SAS requires cooperation between specialists...
  17. ncbi request reprint Growth hormone in glucocorticoid-induced osteoporosis
    F Manelli
    Endocrine Section, Department of Internal Medicine, University of Brescia, Italy
    Front Horm Res 30:174-83. 2002
  18. doi request reprint A consensus on criteria for cure of acromegaly
    A Giustina
    Department of Medical and Surgical Sciences, University of Brescia, Endocrine Service, Montichiari Hospital, Via Ciotti 154, 25018 Montichiari, Italy
    J Clin Endocrinol Metab 95:3141-8. 2010
    ..The Acromegaly Consensus Group met in April 2009 to revisit the guidelines on criteria for cure as defined in 2000...
  19. ncbi request reprint GH deficiency in the adult and bone
    M Doga
    Endocrine Section, Department of Internal Medicine, University of Brescia, Brescia, Italy
    J Endocrinol Invest 28:18-23. 2005
    ..To understand if these BMD changes may result in a reduction of fracture risk, it is necessary to carry out a longitudinal follow-up of large cohorts of GHD adults on GH replacement therapy...
  20. ncbi request reprint Effects of intranasal calcitonin administration on pituitary GH response to hGHRH (1-29)NH2 in normal adult subjects
    A Giustina
    Cattedra di Patologia Speciale Medica and Cattedra di Chimica, University of Brescia, Italy
    Clin Endocrinol (Oxf) 30:699-704. 1989
    ..n. sCT 551 +/- 116 micrograms 120 min/l. P less than 0.001; or vs GHRH plus i.m. sCT 700 +/- 167 micrograms 120 min/l, P less than 0.001. We conclude that sCT is able to inhibit GHRH-stimulated GH secretion in man...
  21. doi request reprint New understanding and treatments for osteoporosis
    G Mazziotti
    Department of Medical and Surgical Sciences, University of Brescia, Brescia, Italy
    Endocrine 41:58-69. 2012
    ..Future research is needed to address the efficacy of anti-osteoporotic drugs in these more recently recognized conditions of skeletal fragility. Osteoporosis continues to be an important field of biomedical research...
  22. ncbi request reprint Cardiopulmonary adaptation to exercise after acute weight loss in severely obese subjects
    E Boni
    Dept of Internal Medicine, University of Brescia, Italy
    Monaldi Arch Chest Dis 50:264-8. 1995
    ..Moreover, this acute weight loss is able to partially reverse all of the cardiopulmonary alterations seen in obese patients both at baseline and during exercise...
  23. ncbi request reprint Effects of metoclopramide on the growth hormone response to galanin in normal man
    A Giustina
    Cattedra di Clinica Medica, University of Brescia, Italy
    Horm Metab Res 25:489-92. 1993
    ..4 +/- 1.6 micrograms/l). During MCP infusion no significant differences in the GH response to galanin with respect to saline were observed both when absolute GH levels and GH AUC were examined.(ABSTRACT TRUNCATED AT 250 WORDS)..
  24. ncbi request reprint Development of acromegaly in a patient with anorexia nervosa: pathogenetic and diagnostic implications
    E De Menis
    Internal Medicine, Treviso Hospital, Brescia, Italy
    J Endocrinol Invest 29:821-5. 2006
    ..In this clinical report, we describe the development of acromegaly in a patient affected by AN and we discuss pathogenetic and diagnostic implications...
  25. ncbi request reprint Preliminary observations on the effects of acute infusion of growth hormone on coronary vasculature and on myocardial function and energetics of an isolated and blood-perfused heart
    R Lorusso
    Experimental Cardiac Surgery Unit, Ospedale Civile, Brescia, Italy
    J Endocrinol Invest 26:RC1-4. 2003
    ....
  26. doi request reprint Effects of recombinant follicle-stimulating hormone on bone turnover markers in infertile women undergoing in vitro fertilization procedure
    U Omodei
    University of Brescia, 25121 Brescia, Italy
    J Clin Endocrinol Metab 98:330-6. 2013
    ..There is experimental but limited clinical evidence that FSH may have direct effects on bone...
  27. ncbi request reprint Relationship between instrumental activities of daily living and blood glucose control in elderly subjects with type 2 diabetes
    S Bossoni
    Department of Internal Medicine, University of Brescia, Italy
    Age Ageing 37:222-5. 2008
  28. ncbi request reprint Cardiovascular risk in aging and obesity: is there a role for GH
    M Gola
    Endocrine Section, Department of Internal Medicine, University of Brescia, Brescia, Italy
    J Endocrinol Invest 28:759-67. 2005
    ....
  29. ncbi request reprint Prevention and treatment of glucocorticoid-induced osteoporosis
    M Doga
    Department of Internal Medicine, University of Brescia, Brescia, Italy
    J Endocrinol Invest 31:53-8. 2008
    ..Anabolic therapeutic strategies are under investigation. Teriparatide seems to be also efficacious for the treatment of patients with GIO...
  30. doi request reprint Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary
    R Carpinteri
    Department of Medical and Surgical Sciences, University of Brescia, Endocrine Service, Montichiari Hospital, Via Ciotti 154, 25018 Montichiari, Italy
    Best Pract Res Clin Endocrinol Metab 23:639-50. 2009
    ....
  31. ncbi request reprint Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects
    M Doga
    Department of Internal Medicine, University of Brescia, Italy
    Ann Oncol 12:S89-94. 2001
    ..Finally, the advent of these antagonists has allowed significant progress in the understanding of the role of the central and tissue GHRH-GH-IGFs system in the pathogenesis of tumors...
  32. doi request reprint Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study
    S Gonnelli
    Department of Internal Medicine, Endocrine Metabolic Science, and Biochemistry, University of Siena, Policlinico Le Scotte, Viale Bracci 2, 53100 Siena, Italy
    Calcif Tissue Int 87:137-43. 2010
    ..28, and OR = 1.40, CI 1.06-1.82, respectively). In conclusion, in COPD patients high doses of inhaled GCs, but not beta(2) agonists, are associated with an increased risk of vertebral fractures and a reduction of QUS at the calcaneus...
  33. ncbi request reprint Role of growth hormone in chronic heart failure. Therapeutic implications
    M Volterrani
    Fondazione S Maugeri, Cardiology Department, Gussago Medical Centre, Brescia, Italy
    Drugs 60:711-9. 2000
    ..Whether GH treatment will finally find a place, and with which modalities, in the treatment of heart failure remains to be established...
  34. doi request reprint Prevalence of thoracic vertebral fractures in hospitalized elderly patients with heart failure
    G Mazziotti
    Endocrinology, University of Brescia, Brescia, Italy
    Eur J Endocrinol 167:865-72. 2012
    ..Indeed, most literature data on fractures were based on an historical and clinical approach focused on the identification of peripheral fractures, whereas the risk of vertebral fractures in this clinical setting is still unclear...
  35. ncbi request reprint Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study
    A Giustina
    Department of Medical and Surgical Sciences, University of Brescia, Brescia, Italy
    J Endocrinol Invest 31:731-8. 2008
    ..However, as for other guidelines previously issued in the field, no data are available on their clinical application...
  36. ncbi request reprint Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults
    A Giustina
    Department of Internal Medicine, University of Brescia, Brescia, Italy
    J Endocrinol Invest 31:820-38. 2008
    ..The meeting was comprised of 66 delegates representing 13 different countries...
  37. ncbi request reprint Effect of pyridostigmine on the hydrocortisone-mediated decrease of circulating growth hormone levels in acromegaly
    A Giustina
    Cattedra di Clinica Medica, University of Brescia, Italy
    Horm Metab Res 26:288-92. 1994
    ..abstract truncated at 250 words)..
  38. ncbi request reprint Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships?
    E De Menis
    Department of Internal Medicine, Hospital of Treviso, Brescia, Italy
    J Endocrinol Invest 26:359-63. 2003
    ..These results suggest that somatostatin-mediated proliferative effect on meningioma cells is not mediated by the subtype 2 of the somatostatin receptor...
  39. ncbi request reprint Baseline and stimulated catecholamine secretion in normotensive patients with active acromegaly: acute effects of continuous octreotide infusion
    G D Rio
    Department of Internal Medicine, Section of Endocrinology and Metabolism, University of Modena, Italy
    Eur J Endocrinol 142:179-86. 2000
    ..Since few data are available on the catecholamine secretory dynamics in active acromegaly and no evidence exists on catecholamine variations during GH decrease, we studied acromegalic patients before and during octreotide administration...
  40. ncbi request reprint A single dose of aztreonam in the prevention of urinary tract infections in elderly catheterized patients
    G Romanelli
    Cattedra di Patologia Speciale Medica, University of Brescia, Italy
    J Chemother 2:178-81. 1990
    ..3%) had negative urine without clinical signs of UTI. In conclusion, our data suggest that a single 2g i.m. dose of aztreonam is effective in preventing UTI in elderly patients needing indwelling urethral catheterization...
  41. ncbi request reprint Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy
    A Giustina
    Cattedra di Clinica Medica, University of Brescia, Italy
    Horm Metab Res 24:240-3. 1992
    ..Clonidine is not able to enhance GH secretion similar to GHRH in patients chronically treated with steroids. It can be hypothesized that clonidine does not elicit GH secretion decreasing hypothalamic somatostatin tone...
  42. ncbi request reprint Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment
    G Tulipano
    Department of Biomedical Sciences and Biotechnology, University of Brescia, 25125 Brescia, Italy
    Endocrinology 143:1218-24. 2002
    ..Based on prior reports that sst2 tonically suppresses glucagon secretion, the antagonist most likely increased glucagon secretion from the pancreatic alpha-cells, with resultant increases in plasma glucose and then insulin...
  43. ncbi request reprint GH-releasing peptides and bone
    D Cocchi
    Department of Biomedical Sciences and Biotechnologies, University of Milano, Italy
    J Endocrinol Invest 28:11-4. 2005
    ..These results would indicate that only osteoblasts from fetal bone express functional receptors responsive to ghrelin and GHS...
  44. ncbi request reprint Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I
    S B Solerte
    Department of Internal Medicine, Geriatrics and Gerontologic Clinic and School of Endocrinology and Metabolism, University of Pavia, Italy
    J Clin Endocrinol Metab 84:3260-7. 1999
    ..The higher NKCC response to DHEAS found in old subjects than in younger might counterbalance the age-dependent decline in circulating DHEAS, thus contributing to maintain the pattern of NK immunity during aging...
  45. ncbi request reprint Bacteriological and clinical evaluation of cefotetan in the treatment of severe infections in hospitalized patients
    G Romanelli
    Department of Internal Medicine, University of Brescia, Italy
    Drugs Exp Clin Res 14:411-7. 1988
    ..In conclusion, cefotetan appears to be safe and highly effective for the treatment of severe infections in hospitalized patients...
  46. ncbi request reprint Diagnostic and therapeutic consensus on acromegaly
    M Doga
    Endocrine Section, Department of Internal Medicine, University of Brescia, Brescia, Italy
    J Endocrinol Invest 28:56-60. 2005
    ..This review paper summarizes the main points of the two consensus statements published following these two workshops...
  47. ncbi request reprint The negative role of subclinical thyrotoxicosis on the outcome of hospitalized geriatric patients
    S Bossoni
    University of Brescia, Brescia, Italy
    J Endocrinol Invest 25:64-5. 2002
  48. ncbi request reprint Diagnosis and treatment of acromegaly complications
    A Giustina
    University of Brescia, Brescia, Italy
    J Endocrinol Invest 26:1242-7. 2003
    ..Effective management of co-morbid acromegaly complications will lead to improved morbidity and mortality in acromegaly...
  49. ncbi request reprint Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis
    M Doga
    Endocrine Section, Department of Internal Medicine, University of Brescia, Italy
    Front Horm Res 30:150-64. 2002
  50. doi request reprint Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas
    A Fusco
    Section of Endocrinology, Department of Internal Medicine, Universita Cattolica del Sacro Cuore, Via Cassia 901, Rome, Italy
    J Clin Endocrinol Metab 93:2746-50. 2008
    ..Ki-67 is a marker of proliferation activity associated with invasiveness and prognosis in human tumors...
  51. ncbi request reprint Diagnosis and complications of Cushing's syndrome: a consensus statement
    G Arnaldi
    Department of Internal Medicine, University of Ancona, 60100 Ancona, Italy
    J Clin Endocrinol Metab 88:5593-602. 2003
    ..The consensus statement on diagnostic criteria and the diagnosis and treatment of complications of this syndrome reached at the workshop is hereby summarized...
  52. ncbi request reprint IGF-I, IGFBP-2 and -3 but not GH concentrations are different in normal and poor growing piglets
    R Saleri
    Istituto di Fisiologia Veterinaria, , Italy
    Reprod Nutr Dev 41:163-72. 2001
    ..Piglet weight was positively correlated (r = 0.98, p < 0.001) with IGF-I and IGFBP-2 or -3 concentrations. Our data indicate that growth rate was not correlated to basal or secretagogue-induced GH secretion...
  53. ncbi request reprint Leptin regulates GH gene expression and secretion and nitric oxide production in pig pituitary cells
    M Baratta
    Department Animal Production, Veterinary Biotechnology and Food Safety, University of Parma, 43100 Parma, Italy
    Endocrinology 143:551-7. 2002
    ..01-1000 nM) significantly (P < 0.05) stimulated GH secretion. These data demonstrate that leptin directly influences GH regulation at the pituitary level, and nitric oxide may be involved in this function...
  54. ncbi request reprint Effects of galanin on growth hormone and prolactin secretion in anorexia nervosa
    L De Marinis
    Institute of Endocrinology and Department of Internal Medicine II, Catholic University, Rome, Italy
    Metabolism 49:155-9. 2000
    ..Finally, GAL may act as a PRL secretagogue in AN patients...
  55. ncbi request reprint Growth hormone secretagogue (GHS) analogue, hexarelin stimulates GH from peripheral lymphocytes
    L Poppi
    Institute of Animal Science, 31535 Neustadt, Germany
    Exp Clin Endocrinol Diabetes 110:343-7. 2002
    ..GHRH stimulated lymphocytic GH secretion, whereas, somatostatin had no effect. This study reports for the first time that hexarelin stimulates the secretion of GH from peripheral lymphocytes...
  56. ncbi request reprint Pegvisomant in acromegaly: why, when, how
    A Colao
    Department of Molecular and Clinical Endocrinology and Oncology, University Federico II of Naples, Naples, Italy
    J Endocrinol Invest 30:693-9. 2007
  57. ncbi request reprint Consensus statement: medical management of acromegaly
    S Melmed
    Cedar Sinai Research Institute, UCLA School of Medicine, Los Angeles, USA
    Eur J Endocrinol 153:737-40. 2005
    ..The meeting was supported by an unrestricted educational grant from Ipsen. No pharmaceutical representatives participated in the program planning or in the scientific deliberations...
  58. ncbi request reprint Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients
    L De Marinis
    Departments of Endocrinology and Neurosurgery, Catholic University School of Medicine, Via Cassia 901, 00189 Rome, Italy
    Metabolism 51:616-21. 2002
    ....